Cerenome (CNSY) EBITDA Margin (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBITDA Margin (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 19.75% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -0.36% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -2,203.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,203.65% |
| Mar 31, 2026 | -692.51% |
| Dec 31, 2025 | -420.04% |
| Sep 30, 2025 | -320.83% |
| Jun 30, 2025 | -110.65% |
| Mar 31, 2025 | -333.90% |
| Dec 31, 2024 | -276.20% |
| Sep 30, 2024 | -260.92% |
| Jun 30, 2024 | -289.05% |
| Mar 31, 2024 | -196.72% |
| Dec 31, 2023 | -293.83% |
| Sep 30, 2023 | -73.89% |
| Jun 30, 2023 | -78.42% |
| Mar 31, 2023 | -933.20% |
| Dec 31, 2022 | -3,690.07% |
| Sep 30, 2022 | -6,978.08% |
| Mar 31, 2019 | -308.11% |
| Dec 31, 2018 | -134.32% |
| Sep 30, 2018 | -259.56% |
| Jun 30, 2018 | -279.70% |